Vanessa Gonzalez
- Oncology top 0.2%
- Immunology top 1%
- Molecular Biology top 5%
- Genetics top 1%
- Biomedical Engineering top 2%
- Co-authors
- Simon F. LaceyCarl H. JuneJ. Joseph MelenhorstBruce L. LevineStephan A. GruppAnne ChewNoelle V. FreyPamela A. Shaw
- Topics
- CAR-T cell therapy research (16 papers)Virus-based gene therapy research (4 papers)CRISPR and Genetic Engineering (3 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesBelgiumDenmark
In The Last Decade
Vanessa Gonzalez
18 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 5.0k
- Immunology 1.8k
- Molecular Biology 1.5k
- Genetics 1.5k
- Biomedical Engineering 1.4k
Countries citing papers authored by Vanessa Gonzalez
This map shows the geographic impact of Vanessa Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Gonzalez more than expected).
Fields of papers citing papers by Vanessa Gonzalez
This network shows the impact of papers produced by Vanessa Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Gonzalez. The network helps show where Vanessa Gonzalez may publish in the future.
Co-authorship network of co-authors of Vanessa Gonzalez
This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Gonzalez. A scholar is included among the top collaborators of Vanessa Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Gonzalez. Vanessa Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 10 | |
| 11 | 30 | |
| 12 | 121 | |
| 13 | 18 | |
| 14 | 91 | |
| 15 | 79 | |
| 16 | 3 | |
| 17 | 4 | |
| 18 | Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiabreakdown → | 1317 |
| 19 | 6 | |
| 20 | Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemiabreakdown → | 3933 |
About Vanessa Gonzalez
Vanessa Gonzalez is a scholar working on Oncology, Genetics and Gastroenterology, having authored 20 papers that have together received 5.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Virus-based gene therapy research (4 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Oncology (5.0k citations), Immunology (1.8k citations) and Genetics (1.5k citations). Vanessa Gonzalez has collaborated with scholars based in United States, Belgium and Denmark. Frequent co-authors include Simon F. Lacey, Carl H. June, J. Joseph Melenhorst, Bruce L. Levine, Stephan A. Grupp, Anne Chew, Noelle V. Frey, Pamela A. Shaw, Angela Shen and Zhaohui Zheng. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.